Elekta is committed to the development of cancer care. The company offers ongoing professional education awards and also encourages the adoption of standards to support the interoperability of multi-component systems. Learn more about our current programs summarized below.

Research Grants

Elekta can support investigator initiated Research and Development Agreement Projects via a number of mechanisms that include the provision of research funds, information, access to research hardware and/or software, and access to other Elekta resources. In exchange, Elekta expects to benefit in the form of information, access to intellectual property and research results that are the products of your work.

Elekta Investigator Initiated Research Grant Application


General Information

Elekta has a long and rich tradition of supporting investigator initiated research that leads to advances in technology and clinical care.  We depend on close collaborative relationships with investigators who are themselves leaders in their respective fields. These relationships and the results of our joint research efforts are among the keys to our success and leadership in our industry.

In order to maintain the highest standards, we have formulated a process to guide applicants through the research application. This process is intended to result in a well-defined and high quality research program that is mutually beneficial.

Elekta’s Research Collaborations Program acts in accordance with international and US Federal regulations that govern research funding provided by health care manufacturers to health care providers. The Program complies with the Elekta Code of ConductMedical Imaging and Technology Alliance (MITA) Code of Ethics on Interactions with Healthcare Professionals, the Compliance Program Guidance for Pharmaceutical Manufacturers from the US Office of Inspector General, and US Federal and State Sunshine Reporting of Payments to Physicians.

Elekta can support investigator initiated Research and Development Agreement Projects via various mechanisms that include:

Your work will in turn benefit Elekta in the form of information, access to intellectual property, research results and the like.

To apply for a research grant, please complete the application form. To request a grant application form, please email your request to Scientific.Research@elekta.com.

This application has been adapted from U.S. National Institution of Health applications that are likely familiar to you.  Applications should be focused, achievable and not overly ambitious.  Please note that Elekta places a high value on having clearly defined goals and tasks, meeting specific milestones and providing associated deliverables.  It should be made clear how these goals would be met and the tasks achieved.  Please also limit your requests to that which would be required to complete the project.


Elekta Research Grant Objectives

The Elekta Research Grant Program is intended to support clinical and technological research activities that will advance knowledge and promote innovation. Research proposals shall be expected to demonstrate strong potential for clinical innovation, technological innovation or commercialization, relating to advancements in Elekta products and clinical solutions including Stereotactic Body Radiotherapy (SBRT).


Research Grant Evaluation Process

Elekta’s research committee meets on a regular basis to review grant applications. We make our best effort  to respond to you within 8-12 weeks of receipt of a completed application. If approved, we will work with you to develop a formal Research Agreement between Elekta and your Institution. The project only begins after the Research Agreement has been executed. No commitments should be made by the researcher in anticipation of this event.


Indirect Costs

In an effort to optimize the balance between direct research contributions and research overhead costs, Elekta has established a corporate policy to support a maximum funding level for Indirect Costs of 25%. This is consistent with, and in some cases in excess of Industry-wide funding levels as well as indirect funding levels of substantially larger research support programs that are not Industry-based.

For more information, please contact: Scientific.Research@elekta.com.

SBRT Research Grants

Elekta places particular emphasis on research that advances the use of linear-accelerator based stereotactic body radiation therapy (SBRT) and stereotactic radiation therapy (SRT). Applications related to the use of linear accelerator based SBRT are strongly encouraged, and will be preferentially considered.


Stereotactic Radiation Therapy Research (SBRT and SRT)

Elekta places particular emphasis on research that advances the use of linear-accelerator based stereotactic body radiation therapy (SBRT) and stereotactic radiation therapy (SRT). Applications related to the use of linear accelerator based SBRT are strongly encouraged, and will be preferentially considered.


The Elekta Stereotactic Radiation Therapy Research Grant Program

The development of Stereotactic Body Radiation Therapy has evolved significantly over the last two decades. Today, SBRT is in common use for treatment of tumors in many anatomical sites. Strong belief that the technique has significant potential for improving outcomes and reducing costs is in part driving these efforts. Techniques and resultant outcomes, however, vary widely and there is still much to learn.


The Elekta Stereotactic Radiation Therapy Research Grant Objective

Consequently, Elekta is promoting efforts to advance the understanding of SBRT, particularly as it relates to its delivery using linear accelerator technology. A substantial proportion of our near-term research and development efforts will center on SBRT, and we invite our research partners to participate in these activities. Our granting mechanism is aimed at facilitating these efforts, and we encourage applications directed at these goals.


How to apply

Please refer to the 'Research Grants' section above for general information about research grants and compliance with international and US regulations. You will also find information about the grant evaluation process and the Elekta policy on indirect costs.

For further information or to request a grant application form, please email your request to Scientific.Research@elekta.com.

OpenRT Certification


Elekta’s OpenRT Certification program establishes compliance, validation, deployment, and support standards to support the interoperability of multi-component systems and to enhance quality of care. 


Streamlined Interoperability Between RTP & Elekta's EMR

At Elekta, we believe that standards compliance and system-wide functionality are essential aspects of developing integrated tools to improve overall process efficiency. Elekta’s OpenRT Certification program establishes compliance, validation, deployment, and support standards to support the interoperability of multi-component systems and to enhance quality of care. With OpenRT Certification, customers can purchase the treatment planning system and the EMR/V&R system of their choice without worrying if the systems will work together.


Standards Compliance & Seamless Implementation

The program ensures connectivity between the treatment planning system, Elekta's electronic medical record (EMR), and the linear accelerator by requiring vendors to transfer all of the data needed to effectively manage treatment planning, setup, and delivery.


Single-Point™ Customer Support

With OpenRT Certification, technical support is available in a single phone call. Customers may contact either Elekta or their treatment planning vendor to resolve any problems that arise.


Participating Companies

Elekta would like to acknowledge NOMOS and Philips in their efforts to join us in establishing a program to ensure interoperability across multiple systems.


Questions or Comments?

Please contact the program administrator, Leon Tomczyk, for additional information.

Oncology Data Alliance

The mission of the Elekta Software Oncology Data Alliance (ODA) is to improve patient cancer care through the analysis of aggregate oncology data. 

The goal of the Oncology Data Alliance (ODA) is to improve patient cancer care through the analysis of aggregate oncology data. This data alliance will be unique in that:

As always, Elekta will apply and set standards for quality data and will incorporate feedback from current customers to make this a unique and valuable evaluation and research tool for oncology treatment centers. Benchmark reports can help our current customers to maximize their investment in Elekta software. With a team focusing on the ODA, there will be a dedicated Elekta employee available to assist with quality assurance and data quality of the ODA at individual customer sites as well as the database as a whole. These benchmarking reports will allow participating facilities to:

Each participant enters into a two-year renewable term and is asked to complete a minimum dataset requirement in order to maintain a high standard of quality. In addition, participating facilities will:

For more program information, contact Dave Eggert

Registrar of the Year

Elekta Software’s Registrar of the Year program honors outstanding Elekta Software cancer registrars who have made valuable contributions to the success of the registry and have expanded their contributions to the broader facility and community. 

Leksell Radiosurgery Award

Elekta sponsors this award which is presented annually at the AANS meeting. Started in 2009, the award is for the best paper on stereotactic radiosurgery as related to brain tumors. 

Each year Elekta sponsors an award for the best paper on stereotactic radiosurgery related to brain tumors amongst the Tumor Section members of AANS and CNS. Winners are presented at the AANS Annual Meeting.

NODA Voluntary Call for Data

Elekta Software registry customers regularly contribute data to Elekta Software’s National Oncology DataBase™ (NODB) through quality-checked submissions directly from their registry software. In return, Elekta Software provides primary site-specific aggregate data reports to contributors via the Internet. Elekta Software’s registry customers can use this information to generate annual reports, internal comparative reviews, and much more.

Citation Guidelines

Frequently, Elekta is asked about the proper way to cite the use our products in the professional literature, in professional meeting posters or in oral presentations. Because Elekta has grown as an entity both organically and by acquisition of leading industry corporations and their products, there has been considerable confusion about the proper citation language.
 


Stereotactic Radiotherapy Publications Support Program

To demonstrate our commitment to the delivery of world class stereotactic solutions for linear accelerator users, Elekta introduces a program aimed at supporting our collaboration and research partners.